Speaker

Katie Phillips

Senior Director of Accounting, Alnylam Pharmaceuticals, Inc.

Katie Phillips, Senior Director of Accounting at Alnylam Pharmaceuticals, Inc., spoke at Finance & Accounting for Bioscience (Boston, United States of America, 24–25 Sept 2026) in the session “Revenue Recognition & GTN Strategies: Optimize Processes and Build Scalable Systems”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

Finance & Accounting for Bioscience
24–25 Sept 2026Boston, United States of America
- SpeakerRevenue Recognition & GTN Strategies: Optimize Processes and Build Scalable SystemsWith Ryan McNally, Meagan Caldwell, Lydia Wu

More speakers at Finance & Accounting for Bioscience

Maricel Apuli
Chief Accounting Officer, BridgeBio
Maggie Berkeley
Biopharma Sector Leader and Risk Advisory Principal, RSM US LLP
Juan Betanzo
Vice President, Strategic Finance, EyePoint
Kwame Boateng
Independent
Kathleen Borthwick
Chief Financial Officer, Passage Bio
Melissa Bradford-Klug
Chief Financial & Business Officer, NorthSea Therapeutics

See all 38 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Katie Phillips, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].